.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Citi
Fish and Richardson
Fuji
Federal Trade Commission
Moodys
Covington
Deloitte
McKinsey
Colorcon

Generated: July 24, 2017

DrugPatentWatch Database Preview

Epinephrine bitartrate; prilocaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for epinephrine bitartrate; prilocaine hydrochloride and what is the scope of epinephrine bitartrate; prilocaine hydrochloride freedom to operate?

Epinephrine bitartrate; prilocaine hydrochloride
is the generic ingredient in three branded drugs marketed by Septodont Inc, Astrazeneca, and Dentsply Pharm, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for epinephrine bitartrate; prilocaine hydrochloride. Two suppliers are listed for this compound.

Summary for Generic Name: epinephrine bitartrate; prilocaine hydrochloride

Tradenames:3
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list19
Suppliers / Packagers: see list2
Clinical Trials: see list2,674
Drug Prices:see low prices
DailyMed Link:epinephrine bitartrate; prilocaine hydrochloride at DailyMed

Pharmacology for Ingredient: epinephrine bitartrate; prilocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Septodont Inc
PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE
epinephrine bitartrate; prilocaine hydrochloride
INJECTABLE;INJECTION078959-001Aug 30, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Dentsply Pharm
CITANEST FORTE DENTAL
epinephrine bitartrate; prilocaine hydrochloride
INJECTABLE;INJECTION021383-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Astrazeneca
CITANEST FORTE
epinephrine bitartrate; prilocaine hydrochloride
INJECTABLE;INJECTION014763-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Chubb
Farmers Insurance
Cantor Fitzgerald
Moodys
US Army
Argus Health
Cerilliant
Harvard Business School
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot